197 related articles for article (PubMed ID: 2227570)
1. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers in bronchogenic carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
Acta Radiol Oncol; 1983; 22(3):209-14. PubMed ID: 6312760
[TBL] [Abstract][Full Text] [Related]
4. Placental alkaline phosphatase (PLAP)/PLAP-like alkaline phosphatase as tumour marker in relation to CA 125 and TPA for ovarian epithelial tumours.
Stigbrand T; Riklund K; Tholander B; Hirano K; Lalos O; Stendahl U
Eur J Gynaecol Oncol; 1990; 11(5):351-60. PubMed ID: 2097151
[TBL] [Abstract][Full Text] [Related]
5. Tumor markers in mammary carcinoma. An evaluation of carcinoembryonic antigen, placental alkaline phosphatase, pseudouridine and CA-50.
Rasmuson T; Björk GR; Damber L; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
Acta Oncol; 1987; 26(4):261-7. PubMed ID: 3479987
[TBL] [Abstract][Full Text] [Related]
6. CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinoma.
Toftager-Larsen K; Hørding U; Dreisler A; Daugaard S; Lund B; Bock J; Lundvall F; Frederiksen K; Nørgaard-Pedersen B
Gynecol Obstet Invest; 1992; 33(3):177-82. PubMed ID: 1319386
[TBL] [Abstract][Full Text] [Related]
7. Significance of alkaline phosphatase isozymes in the monitoring of patients with colorectal carcinoma.
Harmenberg U; Frödin JE; Ljungdahl-Stähle E; Mellstedt H; Wahren B; Stigbrand T
Tumour Biol; 1989; 10(5):225-31. PubMed ID: 2814231
[TBL] [Abstract][Full Text] [Related]
8. CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.
Hørding U; Toftager-Larsen K; Dreisler A; Lund B; Daugaard S; Lundvall F; Arends J; Winkel P; Rørth M
Gynecol Obstet Invest; 1990; 30(3):178-83. PubMed ID: 2265805
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
[TBL] [Abstract][Full Text] [Related]
10. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
Casetta G; Cavallini A; Piana P; Squintone L; Vottero M; Tizzani A
Minerva Urol Nefrol; 1992; 44(3):169-72. PubMed ID: 1492266
[TBL] [Abstract][Full Text] [Related]
12. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
[TBL] [Abstract][Full Text] [Related]
13. Sialyl-Tn, sialyl-Lewis Xi, CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors.
Inoue M; Fujita M; Nakazawa A; Ogawa H; Tanizawa O
Obstet Gynecol; 1992 Mar; 79(3):434-40. PubMed ID: 1346716
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers in colorectal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
Acta Radiol Oncol; 1984; 23(1):27-32. PubMed ID: 6328884
[TBL] [Abstract][Full Text] [Related]
15. CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma.
Vergote IB; Abeler VM; Børmer OP; Stigbrand T; Tropé C; Nustad K
Tumour Biol; 1992; 13(3):168-74. PubMed ID: 1626181
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.
Duk JM; De Bruijn HW; Groenier KH; Fleuren GJ; Aalders JG
Cancer; 1990 Apr; 65(8):1830-7. PubMed ID: 2317761
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma.
Wobbes T; Thomas CM; Segers MF; Nagengast FM
Cancer; 1992 Apr; 69(8):2036-41. PubMed ID: 1544112
[TBL] [Abstract][Full Text] [Related]
18. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sekiya S; Takamizawa H; Suzuki N; Tokita H
Arch Gynecol Obstet; 1988; 243(2):69-81. PubMed ID: 3165255
[TBL] [Abstract][Full Text] [Related]
19. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
Kataoka A; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
[TBL] [Abstract][Full Text] [Related]
20. Placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases.
Eerdekens MW; Nouwen EJ; Pollet DE; Briers TW; De Broe ME
Clin Chem; 1985 May; 31(5):687-90. PubMed ID: 3857128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
